Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase i studies

HIGHLIGHTS

• who: Uwe Platzbecker from the Medical Clinic and Policlinic, Hematology and Cellular Therapy, University Hospital Leipzig, Johannisallee, Du2011, Leipzig, Germany have published the article: Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies, in the Journal: (JOURNAL)
• what: The study was stopped after these 16 patients were treated due to discontinuation of the development of volasertib for non-clinical reasons.
• future: All studies were terminated prematurely following the discontinuation of for non-clinical reasons by . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.